Caprock Group, Inc. Novartis Ag Transaction History

Caprock Group, Inc.

$1.72 Billion
Q1 2024

A detailed history of Caprock Group, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Caprock Group, Inc. holds 16,736 shares of NVS stock, worth $1.81 Million. This represents 0.09% of its overall portfolio holdings.

Number of Shares

16,736

Previous 17,153 2.43%

Holding current value

$1.81 Million

Previous $1.73 Million 6.53%

% of portfolio

0.09%

Previous 0.11%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 29, 2024	SELL	$95.27 - $108.47 $39,727 - $45,231	-417 Reduced 2.43%	16,736 $1.62 Million
Q4 2023 Jan 18, 2024	BUY	$92.27 - $101.54 $113,676 - $125,097	1,232 Added 7.74%	17,153 $1.73 Million
Q3 2023 Oct 18, 2023	BUY	$94.73 - $105.13 $97,950 - $108,704	1,034 Added 6.95%	15,921 $1.62 Million
Q2 2023 Aug 10, 2023	BUY	$92.52 - $104.91 $197,622 - $224,087	2,136 Added 16.75%	14,887 $1.5 Million
Q1 2023 Apr 26, 2023	BUY	$80.03 - $92.81 $17,446 - $20,232	218 Added 1.74%	12,751 $1.17 Million

Q4 2022 Jan 23, 2023	SELL	$75.55 - $92.52 $24,251 - $29,698	-321 Reduced 2.5%	12,533 $0
Q3 2022 Nov 07, 2022	SELL	$74.61 - $87.26 $54,465 - $63,699	-730 Reduced 5.37%	12,854 $977,000
Q2 2022 Jul 26, 2022	BUY	$80.52 - $93.75 $140,587 - $163,687	1,746 Added 14.75%	13,584 $1.15 Million
Q1 2022 Apr 12, 2022	BUY	$80.11 - $90.62 $252,026 - $285,090	3,146 Added 36.19%	11,838 $1.04 Million
Q4 2021 Jan 18, 2022	BUY	$79.7 - $88.13 $206,582 - $228,432	2,592 Added 42.49%	8,692 $760,000
Q3 2021 Oct 07, 2021	SELL	$81.78 - $95.14 $15,619 - $18,171	-191 Reduced 3.04%	6,100 $499,000
Q2 2021 Aug 13, 2021	BUY	$85.24 - $94.15 $186,078 - $205,529	2,183 Added 53.14%	6,291 $574,000
Q1 2021 Apr 29, 2021	SELL	$83.5 - $98.47 $12,775 - $15,065	-153 Reduced 3.59%	4,108 $351,000
Q4 2020 Jan 29, 2021	BUY	$78.07 - $94.43 $60,972 - $73,749	781 Added 22.44%	4,261 $402,000
Q3 2020 Oct 29, 2020	SELL	$82.14 - $91.0 $187,525 - $207,753	-2,283 Reduced 39.61%	3,480 $303,000
Q2 2020 Aug 05, 2020	SELL	$80.93 - $91.1 $83,600 - $94,106	-1,033 Reduced 15.2%	5,763 $503,000
Q1 2020 Apr 28, 2020	BUY	$70.67 - $99.01 $117,665 - $164,851	1,665 Added 32.45%	6,796 $560,000
Q4 2019 Feb 04, 2020	BUY	$84.35 - $95.37 $3,964 - $4,482	47 Added 0.92%	5,131 $486,000
Q3 2019 Oct 31, 2019	BUY	$85.54 - $94.26 $16,936 - $18,663	198 Added 4.05%	5,084 $442,000
Q2 2019 Jul 23, 2019	SELL	$75.4 - $92.8 $48,557 - $59,763	-644 Reduced 11.65%	4,886 $446,000
Q1 2019 Apr 12, 2019	BUY	$75.32 - $86.15 $24,027 - $27,481	319 Added 6.12%	5,530 $532,000
Q4 2018 Jan 29, 2019	BUY	$73.66 - $82.02 $47,510 - $52,902	645 Added 14.13%	5,211 $447,000
Q3 2018 Oct 17, 2018	SELL	$66.94 - $77.43 $1,137 - $1,316	-17 Reduced 0.37%	4,566 $393,000
Q2 2018 Jul 23, 2018	SELL	$64.91 - $73.36 $31,546 - $35,652	-486 Reduced 9.59%	4,583 $346,000
Q1 2018 Apr 23, 2018	SELL	$70.39 - $84.15 $10,769 - $12,874	-153 Reduced 2.93%	5,069 $425,000
Q4 2017 Jan 17, 2018	BUY	$72.33 - $77.64 $144 - $155	2 Added 0.04%	5,222 $452,000
Q3 2017 Oct 23, 2017	BUY	$74.14 - $77.27 $387,010 - $403,349	5,220	5,220 $448,000

Others Institutions Holding NVS

# of Institutions

1,350

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $233B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Caprock Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Caprock Group, Inc. with notifications on news.

Account

Caprock Group, Inc. Novartis Ag Transaction History